skip to content

Cambridge Immunology Network

 

Congratulations to Andrew Lever, who won one of the competitive awards to collaborate with GSK.

Andrew Lever is one of the winners of GSK's Discovery Fast Track Challenge - a programme designed to combine the expertise of academic researchers with that of drug discovery scientists at GSK, to accelerate the search for new medicines.

Duncan Holmes, European Head of DPAc, said: “We believe there is a real advantage in bringing together the best in academia and industry to help take innovative ideas forward in drug discovery. The Discovery Fast Track Challenge is designed to find the best ideas for collaborative drug discovery from any therapeutic area, in any geography. We look forward to working with each of the winners to help identify novel quality pharmacologically active compounds for their targets and being part of the researcher’s journey in making a difference.”